Navigate the complex landscape of neurobiology as we analyze a controversial new study that challenges long-held beliefs about ADHD medications and supplemental interventions. This episode bridges the gap between clinical data and lived experience, examining how "tiny" research findings can disrupt the trillion-dollar pharmaceutical industry and what the gold-standard longitudinal studies actually reveal about brain function. Optimized for mental health professionals and curious minds alike, we provide an evidence-based roadmap to help you distinguish between viral health trends and genuine neuro-scientific breakthroughs.